NatWest Group’s Mead Johnson Nutrition Company MJN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-8,427
Closed -$593K 390
2015
Q3
$593K Sell
8,427
-87,676
-91% -$7.21M 0.01% 263
2015
Q2
$8.67M Sell
96,103
-2,005
-2% -$193K 0.11% 73
2015
Q1
$9.86M Sell
98,108
-1,471
-1% -$148K 0.13% 71
2014
Q4
$10K Sell
99,579
-2,916
-3% -$291K 0.09% 73
2014
Q3
$9.86K Buy
102,495
+950
+0.9% +$90K 0.08% 81
2014
Q2
$9.46M Buy
101,545
+32,181
+46% +$2.81M 0.4% 75
2014
Q1
$5.77M Sell
69,364
-10,720
-13% -$869K 0.26% 112
2013
Q4
$6.71M Buy
80,084
+65,290
+441% +$5.32M 0.17% 136
2013
Q3
$1.1M Sell
14,794
-1,494
-9% -$112K 0.03% 397
2013
Q2
$1.29M Buy
+16,288
New +$1.31M 0.02% 420

Other funds holding MJN

NatWest Group's MJN Position: Q4 2015 in Review

NatWest Group sold out of Mead Johnson Nutrition Company (MJN) in Q4 2015, closing a stake of 8,427 shares — an estimated $593K sold.

NatWest Group first reported a position in MJN in Q2 2013 and held it in 10 quarters. The position peaked at $9.86M in Q1 2015. 549 funds tracked by Wall St. Rank hold MJN as of Q4 2015.

  • NatWest Group reported no remaining Mead Johnson Nutrition Company position as of Q4 2015 after selling out during the quarter.
  • NatWest Group sold 8,427 Mead Johnson Nutrition Company shares in Q4 2015, an estimated $593K.
  • NatWest Group first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 10 quarters.
  • NatWest Group's Mead Johnson Nutrition Company position peaked at $9.86M in Q1 2015.
  • 549 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q4 2015.

Based on NatWest Group's 13F filing for Q4 2015, filed 16 Feb 2016.